STEMI: Considerations for Left Main Culprit Lesions

Author:

Ahmed Ameera,Aguirre Frank V.,Chambers Jenny,Sharkey Scott W.,Tannenbaum Mark A.,Yildiz Mehmet,Garberich Ross,Garcia Santiago,Henry Timothy D.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Baek JY, Seo SM, Park HJ, Kim PJ, Park MW, Koh YS, Chang KY, Jeong MH, Park SJ, Seung KB. Clinical outcomes and predictors of unprotected left main stem culprit lesions in patients with acute ST segment elevation myocardial infarction. Catheter Cardiovasc Interv. 2014;1(83):e243-250.

2. Lee M, Sillano D, Latib A, Chieffo A, Biondi Zoccai G, Bhatia R, Sheiban I, Colombo A, Tobis J. Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction. Catheter Cardiovasc Interv. 2009;73:15–21.

3. Montalescot G, Brieger D, Eagle KA, Anderson FA Jr, FitzGerald G, Lee MS, Steg PG, Avezum A, Goodman SG, Gore JM. GRACE Investigators. Unprotected left main revascularization in patients with acute coronary syndromes Eur Heart J. 2009;30:2308–17.

4. Pappalardo A, Mamas MA, Imola F, Ramazzotti V, Manzoli A, Prati F, El-Omar M. Percutaneous coronary intervention of unprotected left main coronary artery disease as culprit lesion in patients with acute myocardial infarction. JACC Cardiovasc Interv. 2011;4:618–26.

5. • Pedrazzini GB, Radovanovic D, Vassalli, El-Omar, Sürder D, Moccetti T, Eberli F, Urban P, Windecker S, Rickli H, Erne P. AMIS Plus Investigators. Primary percutaneous coronary intervention for unprotected left main disease in patients with acute ST-segment elevation myocardial infarction the AMIS (Acute Myocardial Infarction in Switzerland) plus registry experience. JACC Cardiovasc Interv. 2011;4(6):627–633. Findings from this study suggest that patients with LM STEMI have higher incidence of cardiogenic shock, MACE, and mortality compared to non-LM culprits.

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3